Literature DB >> 23114594

DGAT1 mutation is linked to a congenital diarrheal disorder.

Joel T Haas1, Harland S Winter, Elaine Lim, Andrew Kirby, Brendan Blumenstiel, Matthew DeFelice, Stacey Gabriel, Chaim Jalas, David Branski, Carrie A Grueter, Mauro S Toporovski, Tobias C Walther, Mark J Daly, Robert V Farese.   

Abstract

Congenital diarrheal disorders (CDDs) are a collection of rare, heterogeneous enteropathies with early onset and often severe outcomes. Here, we report a family of Ashkenazi Jewish descent, with 2 out of 3 children affected by CDD. Both affected children presented 3 days after birth with severe, intractable diarrhea. One child died from complications at age 17 months. The second child showed marked improvement, with resolution of most symptoms at 10 to 12 months of age. Using exome sequencing, we identified a rare splice site mutation in the DGAT1 gene and found that both affected children were homozygous carriers. Molecular analysis of the mutant allele indicated a total loss of function, with no detectable DGAT1 protein or activity produced. The precise cause of diarrhea is unknown, but we speculate that it relates to abnormal fat absorption and buildup of DGAT substrates in the intestinal mucosa. Our results identify DGAT1 loss-of-function mutations as a rare cause of CDDs. These findings prompt concern for DGAT1 inhibition in humans, which is being assessed for treating metabolic and other diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114594      PMCID: PMC3533555          DOI: 10.1172/JCI64873

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling.

Authors:  K Hofmann
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases.

Authors:  Montgomery Slatkin
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

3.  Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor.

Authors:  Gang Zhao; Andrew J Souers; Martin Voorbach; H Doug Falls; Brian Droz; Sevan Brodjian; Yau Yi Lau; Rajesh R Iyengar; Ju Gao; Andrew S Judd; Seble H Wagaw; Matthew M Ravn; Kenneth M Engstrom; John K Lynch; Mathew M Mulhern; Jennifer Freeman; Brian D Dayton; Xiaojun Wang; Nelson Grihalde; Dennis Fry; David W A Beno; Kennan C Marsh; Zhi Su; Gilbert J Diaz; Christine A Collins; Hing Sham; Regina M Reilly; Michael E Brune; Philip R Kym
Journal:  J Med Chem       Date:  2008-01-10       Impact factor: 7.446

4.  Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members.

Authors:  S Cases; S J Stone; P Zhou; E Yen; B Tow; K D Lardizabal; T Voelker; R V Farese
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

5.  DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis.

Authors:  Kimberly K Buhman; Steven J Smith; Scot J Stone; Joyce J Repa; Jinny S Wong; F F Knapp; Betty J Burri; Robert L Hamilton; Nada A Abumrad; Robert V Farese
Journal:  J Biol Chem       Date:  2002-04-16       Impact factor: 5.157

6.  Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing.

Authors:  Michael Krawczak; Nick S T Thomas; Bernd Hundrieser; Matthew Mort; Michael Wittig; Jochen Hampe; David N Cooper
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

7.  Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis.

Authors:  S Cases; S J Smith; Y W Zheng; H M Myers; S R Lear; E Sande; S Novak; C Collins; C B Welch; A J Lusis; S K Erickson; R V Farese
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

8.  Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides.

Authors:  U Beil; J R Crouse; K Einarsson; S M Grundy
Journal:  Metabolism       Date:  1982-05       Impact factor: 8.694

9.  Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands.

Authors:  T E Willnow; J Herz
Journal:  J Cell Sci       Date:  1994-03       Impact factor: 5.235

Review 10.  Abetalipoproteinemia: two case reports and literature review.

Authors:  Rola Zamel; Razi Khan; Rebecca L Pollex; Robert A Hegele
Journal:  Orphanet J Rare Dis       Date:  2008-07-08       Impact factor: 4.123

View more
  58 in total

1.  Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.

Authors:  Douglas M Ruderfer; Alexander W Charney; Ben Readhead; Brian A Kidd; Anna K Kähler; Paul J Kenny; Michael J Keiser; Jennifer L Moran; Christina M Hultman; Stuart A Scott; Patrick F Sullivan; Shaun M Purcell; Joel T Dudley; Pamela Sklar
Journal:  Lancet Psychiatry       Date:  2016-02-23       Impact factor: 27.083

Review 2.  Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes.

Authors:  Theresa D'Aquila; Yu-Han Hung; Alicia Carreiro; Kimberly K Buhman
Journal:  Biochim Biophys Acta       Date:  2016-04-20

3.  Dictyostelium discoideum Dgat2 can substitute for the essential function of Dgat1 in triglyceride production but not in ether lipid synthesis.

Authors:  Xiaoli Du; Cornelia Herrfurth; Thomas Gottlieb; Steffen Kawelke; Kristin Feussner; Harald Rühling; Ivo Feussner; Markus Maniak
Journal:  Eukaryot Cell       Date:  2014-02-21

4.  Dgat1 and Dgat2 regulate enterocyte triacylglycerol distribution and alter proteins associated with cytoplasmic lipid droplets in response to dietary fat.

Authors:  Yu-Han Hung; Alicia L Carreiro; Kimberly K Buhman
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-02-27       Impact factor: 4.698

5.  Reversible deficits in apical transporter trafficking associated with deficiency in diacylglycerol acyltransferase.

Authors:  Cameron Schlegel; Lynne A Lapierre; Victoria G Weis; Janice A Williams; Izumi Kaji; Carolina Pinzon-Guzman; Nripesh Prasad; Braden Boone; Angela Jones; Hernan Correa; Shawn E Levy; Xianlin Han; Miao Wang; Kelly Thomsen; Sari Acra; James R Goldenring
Journal:  Traffic       Date:  2018-09-21       Impact factor: 6.215

Review 6.  Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism.

Authors:  Chi-Liang Eric Yen; David W Nelson; Mei-I Yen
Journal:  J Lipid Res       Date:  2014-09-17       Impact factor: 5.922

7.  Intestine-specific deletion of acyl-CoA:monoacylglycerol acyltransferase (MGAT) 2 protects mice from diet-induced obesity and glucose intolerance.

Authors:  David W Nelson; Yu Gao; Mei-I Yen; Chi-Liang Eric Yen
Journal:  J Biol Chem       Date:  2014-05-01       Impact factor: 5.157

8.  Successful Strategies for Mitigation of a Preclinical Signal for Phototoxicity in a DGAT1 Inhibitor.

Authors:  Tyler J Harrison; Daniel Bauer; Alina Berdichevsky; Xin Chen; Rohit Duvadie; Benjamin Hoogheem; Panos Hatsis; Qian Liu; Justin Mao; Vasumathy Miduturu; Erik Rocheford; Frederic Zecri; Richard Zessis; Rui Zheng; Qingming Zhu; Ryan Streeper; Sejal J Patel
Journal:  ACS Med Chem Lett       Date:  2019-06-20       Impact factor: 4.345

9.  Protein Crowding Is a Determinant of Lipid Droplet Protein Composition.

Authors:  Nora Kory; Abdou-Rachid Thiam; Robert V Farese; Tobias C Walther
Journal:  Dev Cell       Date:  2015-07-23       Impact factor: 12.270

10.  Postnatal Deletion of Fat Storage-inducing Transmembrane Protein 2 (FIT2/FITM2) Causes Lethal Enteropathy.

Authors:  Vera J Goh; Jolene S Y Tan; Bryan C Tan; Colin Seow; Wei-Yi Ong; Yen Ching Lim; Lei Sun; Sujoy Ghosh; David L Silver
Journal:  J Biol Chem       Date:  2015-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.